Researcher(s) Keywords:
- meta-analysis
- health communication
- risk behaviors
- Risk perception
Featured Researcher(s):
Date: June 8, 2026

EL PASO, Texas (June 8, 2026) – A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.
Full story: [ Link to University Communications ]

